Mastering IPO Trading: How to Filter New Issues for Real Growth
One metric separates a tradeable IPO from a liquidity trap, according to Investor's Business Daily's latest piece — and Bending Spoons is the live case study.
Nathaniel Prescott, Lead Wealth Strategist & Solo Columnist·updated August 07, 2026
With 2026 markets sitting at record highs and SpaceX widely watched as the next marquee listing, that filter is the only edge retail has against the first-day auction crowd.
What Bending Spoons actually illustrates
IBD's framing: Bending Spoons is a high-profile lesson in handling liquidity in new issues, and that lesson is set to come due for other recent IPOs. The piece pitches a specific metric as the secret to trading names like SpaceX "without breaking a leg." That's the right posture. We don't need conviction on the product roadmap or the TAM slide; we need conviction on price relative to float, allocation tightness, and institutional demand. The post-IPO window forces a binary decision most retail buyers dodge: are you holding the business, or trading the liquidity event? Those are different position sizes, different exit rules, different volatility tolerances. No single position size works for both.
The backdrop isn't neutral
Intellectia is flagging 2026 stock-market record highs. Investing.com notes crypto is participating in the rally with notable caution. Moneycontrol is reframing "retirement" as ongoing business restructuring rather than exit. None of this is irrelevant to the IPO trade. In a melt-up regime, allocations get rationed, retail gets scraps, and post-IPO price discovery becomes a patience game rather than a momentum trade. IBD's current "IPO Stock Of The Week" tag points to a regional name, though the headline in our feed is truncated, so specifics are limited.
What you do with this
Skip the first-day pop trade unless you have a mechanical edge. Size any new-issue position so a 40% drawdown doesn't violate your portfolio plan — because at some point, one of these names will deliver that drawdown, and "eventually" is the only timeline that matters. Read the metric IBD is referencing before you underwrite any allocation. The cost of being early is asymmetric, and in this regime, being early is the default outcome for anyone without institutional access. The opportunity cost of waiting for confirmation is real — but it's cheaper than the cost of holding a bag.